Description
P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€3.03
Related products
-
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart
